Oncotelic’s Patented Lead Anti-Cancer Drug Candidate as Well as Drug Delivery Platform for Brain Tumors on Track for Advanced Pivotal Phase 3 Clinical Testing

World News: . []

AGOURA HILLS Calif July 30 2019 GLOBE NEWSWIRE -- LINK  Inc Oncotelic a wholly owned subsidiary of Mateon Therapeutics Inc LINK  dedicated to the development of innovative treatments for cancer LINK  today that its team m...

More news and information about Mateon Therapeutics

Published By:

Globe Newswire: 13:55 GMT Tuesday 30th July 2019

Published: .

Search for other references to "oncotelic" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us